| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Colella Samuel D is a Director at LAB. Recent filings cover 11 purchases and 0 sales. Those positions are worth an estimated $129K at current prices.
Colella Samuel D's largest disclosed position is in LAB as Director, worth about $129K. Net of sales, the recent Form 4 record there shows accumulation of 110,395 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 11, 2020 | LAB Standard Biotools Inc. | Director | Buy | 20,000 | $2.71 | $54,283.00 | +6.8% | |
| Aug 27, 2019 | LAB Standard Biotools Inc. | Director | Buy | 2,000 | $5.19 | $10,371.80 | +1.7% | |
| Aug 8, 2019 | LAB Standard Biotools Inc. | Director | Buy | 1,000 | $6.65 | $6,653.30 | +0.9% | |
| Aug 7, 2019 | LAB Standard Biotools Inc. | Director | Buy | 9,000 | $7.00 | $63,039.90 | +4.0% | |
| Aug 8, 2017 | LAB Standard Biotools Inc. | Director | Buy | 35,895 | $2.77 | $99,357.36 | +205.1% | |
| May 9, 2017 | LAB Standard Biotools Inc. | Director | Buy | 7,500 | $5.93 | $44,437.50 | +75.0% | |
| Mar 14, 2017 | LAB Standard Biotools Inc. | Director | Buy | 10,000 | $5.00 | $49,973.00 | New | |
| Dec 14, 2016 | LAB Standard Biotools Inc. | Director | Buy | 5,000 | $7.39 | $36,935.00 | +12.8% | |
| Nov 30, 2016 | LAB Standard Biotools Inc. | Director | Buy | 20,000 | $6.32 | $126,470.00 | +104.6% |